Hepatotoxic Drugs

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 17

Hepatotoxic Drugs

Direct Hepatotoxicity:
It is a dose-related liver cell injury by:
A chemical e.g. carbon tetrachloride.
A drug metabolite e.g. acetaminophen.
Direct Hepatotoxic Drugs
Examples:
Aspirin.
Acetaminophen.
Amiodarone.
Alcohol.
Carbon Tetrachloride .
Methotrexate.
Indirect Hepatotoxicity

It is due to Altered Metabolism.


Interference with the metabolism of
bilirubin e.g. by estrogen, androgen or
rifampicin.
Interference with protein synthesis
e.g. corticosteroids and i.v tetracycline
leading to fatty liver.
Indirect Hepatotoxic Drugs
Examples:
Androgen.
Estrogen.
Corticosteroids.
Tetracycline i.v
Immune Reaction
A drug or its metabolite binds to liver cell
membrane and acts as a hapten.
It induces a variety of syndromes:
Inflammatory cholestatic jaundice: It
causes intrahepatic bile ductules
obstruction e.g. chlorpromazine &
chlorpropamide.
Viral hepatitis-like pattern e.g. repeated
administration of halothane, isoniazid &
phenytoin.
Immune Reaction
Inflammatory Pattern like viral
cholestasis hepatitis
Chlorpromazine. Halothane.

Chlorpropamide. Isoniazid.

Erythromycin Phenytoin.
estolate. Valproic acid.
Propylthiouracil. Methyldopa.
Thiazide Acetaminophen.

Aspirin.

Nitrofurantoin.
Diagnosis and Management

Taking a careful drug history.


Viral hepatitis should be excluded.
Exclude other causes of extra- and intra-hepatic
obstructive jaundice.
Monitoring liver function tests. Elevation of serum
transferase enzymes greater than three-fold should
be an indication for drug withdrawal, even if the
patient is asymptomatic.
Avoid diagnostic challenge doses of the offending
drug because it may precipitate fulminant hepatic
failure.
Treatment of jaundice is mainly supportive. It
includes:
Withdrawal of the presumed offending drug.
A high carbohydrate diet, moderate in
protein & adequate in calories.
If itching is severe, use cholestyramine to
enhance bile acid excretion and alleviate the
symptoms.
Treatment of complications such as ascites,
esophageal variceal bleeding accordingly.
Case study

Nouf is 72 year-old with a 12 year history of


type II DM admitted in KFMC with:
Generalized weakness, loss of appetite, rash
over the chest & thighs and increasing
itching.
She also noted dark urine, light-colored
stool and yellow pigmentation of the skin.
Past History:
DM controlled by diet until one month
ago when she was started on
chlorpropamide
HTN treated with hydrochlorothiazide
(HCTZ) & methyldopa for the past four
years.
General Examinations:
She appears weak, icteric.

Slightly tender liver.

Vital signs within normal.


Lab. Findings:
AST: 370 U/L (35 U/L).

ALT: 740 U/L (0-34 U/L).

Alkaline phosphatase 537 U/L (30-120 U/L).

Total/direct bilirubin 87/83 umol/L (17-4


umol/L).
Albumin 4.1 gm/dl (4-6 gm/dl).

All other chemistry data are within normal.


CBC & differential count are normal.
Antinuclear antibody and HB-Ag are
both negative.
U/S: normal biliary tract, no
obstruction in bile duct, gallbladder, or
near the head of pancreas.
Problem Solving

This is a case of drug-induced mixed


cholestatic- cytotoxic hepatic injury.
Possible causes:
Hydrochlorothiazide (HCTZ):
It is unlikely because it is rarely
associated with allergic cholestatic
jaundice and it was used for 4 years.
Methyldopa:
can cause hepatocellular injury (within
the 1st three months).
Rarely causes cholestatic jaundice
(cannot be ruled out without liver
biopsy)
Chlorpropamide:
Has been reported to cause mixed-
cholestatic-cytotoxic injury within 2-6
weeks (most probable cause)
Treatment
Stop chlorpropamide & methyldopa and
substituted them by other drugs.
Nouf was placed on:
1200 calories/day (2000-3000 cal/day).
Low salt diet.
Lente insulin start by 20U/d and increased
according to plasma glucose levels.
HCTZ 50mg BID.
Cholestyramine 4gm/day PO TID for itching

You might also like